Literature DB >> 22157815

The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation.

Björn von Eyss1, Jonas Maaskola, Sebastian Memczak, Katharina Möllmann, Anja Schuetz, Christoph Loddenkemper, Mai-Dinh Tanh, Albrecht Otto, Kathrin Muegge, Udo Heinemann, Nikolaus Rajewsky, Ulrike Ziebold.   

Abstract

The activating E2F-transcription factors are best known for their dependence on the Retinoblastoma protein and their role in cellular proliferation. E2F3 is uniquely amplified in specific human tumours where its expression is inversely correlated with the survival of patients. Here, E2F3B interaction partners were identified by mass spectrometric analysis. We show that the SNF2-like helicase HELLS interacts with E2F3A in vivo and cooperates with its oncogenic functions. Depletion of HELLS severely perturbs the induction of E2F-target genes, hinders cell-cycle re-entry and growth. Using chromatin immmunoprecipitation coupled to sequencing, we identified genome-wide targets of HELLS and E2F3A/B. HELLS binds promoters of active genes, including the trithorax-related MLL1, and co-regulates E2F3-dependent genes. Strikingly, just as E2F3, HELLS is overexpressed in human tumours including prostate cancer, indicating that either factor may contribute to the malignant progression of tumours. Our work reveals that HELLS is important for E2F3 in tumour cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22157815      PMCID: PMC3280551          DOI: 10.1038/emboj.2011.451

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  Specificity in the activation and control of transcription factor E2F-dependent apoptosis.

Authors:  Timothy C Hallstrom; Joseph R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

2.  E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1.

Authors:  Stefan Taubert; Chiara Gorrini; Scott R Frank; Tiziana Parisi; Miriam Fuchs; Ho-Man Chan; David M Livingston; Bruno Amati
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

3.  Association of Lsh, a regulator of DNA methylation, with pericentromeric heterochromatin is dependent on intact heterochromatin.

Authors:  Qingsheng Yan; Edward Cho; Stephen Lockett; Kathrin Muegge
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

4.  Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG.

Authors:  Lin-Quan Sun; David W Lee; Quangeng Zhang; Weihong Xiao; Eric H Raabe; Alan Meeker; Dengshun Miao; David L Huso; Robert J Arceci
Journal:  Genes Dev       Date:  2004-04-22       Impact factor: 11.361

5.  Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

Authors:  Aaron Aslanian; Phillip J Iaquinta; Raluca Verona; Jacqueline A Lees
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

6.  Amplification and overexpression of E2F3 in human bladder cancer.

Authors:  Andrew Feber; Jeremy Clark; Graham Goodwin; Andrew R Dodson; Paul H Smith; Anne Fletcher; Sandra Edwards; Penny Flohr; Alison Falconer; Toby Roe; Gyula Kovacs; Nening Dennis; Cyril Fisher; Richard Wooster; Robert Huddart; Christopher S Foster; Colin S Cooper
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

7.  Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome.

Authors:  Christopher S Foster; Alison Falconer; Andrew R Dodson; Andrew R Norman; Nening Dennis; Anne Fletcher; Christine Southgate; Anna Dowe; David Dearnaley; Sameer Jhavar; Rosalind Eeles; Andrew Feber; Colin S Cooper
Journal:  Oncogene       Date:  2004-08-05       Impact factor: 9.867

8.  E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.

Authors:  Martin Oeggerli; Sanja Tomovska; Peter Schraml; Daniele Calvano-Forte; Salome Schafroth; Ronald Simon; Thomas Gasser; Michael J Mihatsch; Guido Sauter
Journal:  Oncogene       Date:  2004-07-22       Impact factor: 9.867

9.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

10.  Lsh-deficient murine embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis.

Authors:  Tao Fan; Qingsheng Yan; Jiaqiang Huang; Sharon Austin; Edward Cho; Doug Ferris; Kathrin Muegge
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  48 in total

1.  TEAD activity is restrained by MYC and stratifies human breast cancer subtypes.

Authors:  Dana Elster; Laura A Jaenicke; Martin Eilers; Björn von Eyss
Journal:  Cell Cycle       Date:  2016-07-19       Impact factor: 4.534

2.  Tissue-specific targeting of cell fate regulatory genes by E2f factors.

Authors:  L M Julian; Y Liu; C A Pakenham; D Dugal-Tessier; V Ruzhynsky; S Bae; S-Y Tsai; G Leone; R S Slack; A Blais
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

Review 3.  DNA Methylation in Basal Metazoans: Insights from Ctenophores.

Authors:  Emily C Dabe; Rachel S Sanford; Andrea B Kohn; Yelena Bobkova; Leonid L Moroz
Journal:  Integr Comp Biol       Date:  2015-07-14       Impact factor: 3.326

4.  Aryl hydrocarbon receptor activated by benzo (a) pyrene promotes SMARCA6 expression in NSCLC.

Authors:  Chao Mao; Min Wang; Banglun Qian; Lianlian Ouyang; Ying Shi; Na Liu; Ling Chen; Desheng Xiao; Xiang Wang; Ya Cao; Shuang Liu; Yongguang Tao; Wenliang Liu
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

5.  Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.

Authors:  Guoxin Zhang; Zhen Dong; Briana C Prager; Leo Jk Kim; Qiulian Wu; Ryan C Gimple; Xiuxing Wang; Shideng Bao; Petra Hamerlik; Jeremy N Rich
Journal:  JCI Insight       Date:  2019-04-04

6.  The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer.

Authors:  Markus E Diefenbacher; Nikita Popov; Sophia M Blake; Christina Schülein-Völk; Emma Nye; Bradley Spencer-Dene; Laura A Jaenicke; Martin Eilers; Axel Behrens
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

7.  E2F3b over-expression in ovarian carcinomas and in BRCA1 haploinsufficient fallopian tube epithelium.

Authors:  Na Lu Smith; Piri Welcsh; Joshua Z Press; Kathy J Agnew; Rochelle Garcia; Elizabeth M Swisher
Journal:  Genes Chromosomes Cancer       Date:  2012-08-09       Impact factor: 5.006

8.  Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours.

Authors:  Peter Wend; Liang Fang; Qionghua Zhu; Jörg H Schipper; Christoph Loddenkemper; Frauke Kosel; Volker Brinkmann; Klaus Eckert; Simone Hindersin; Jane D Holland; Stephan Lehr; Michael Kahn; Ulrike Ziebold; Walter Birchmeier
Journal:  EMBO J       Date:  2013-06-04       Impact factor: 11.598

Review 9.  Altered primary chromatin structures and their implications in cancer development.

Authors:  Angelo Ferraro
Journal:  Cell Oncol (Dordr)       Date:  2016-03-23       Impact factor: 6.730

10.  Chromatin Remodeling Factor LSH Drives Cancer Progression by Suppressing the Activity of Fumarate Hydratase.

Authors:  Xiaozhen He; Bin Yan; Shuang Liu; Jiantao Jia; Weiwei Lai; Xing Xin; Can-E Tang; Dixian Luo; Tan Tan; Yiqun Jiang; Ying Shi; Yating Liu; Desheng Xiao; Ling Chen; Shao Liu; Chao Mao; Gang Yin; Yan Cheng; Jia Fan; Ya Cao; Kathrin Muegge; Yongguang Tao
Journal:  Cancer Res       Date:  2016-06-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.